115 related articles for article (PubMed ID: 15664806)
1. Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonists.
Belley M; Gallant M; Roy B; Houde K; Lachance N; Labelle M; Trimble LA; Chauret N; Li C; Sawyer N; Tremblay N; Lamontagne S; Carrière MC; Denis D; Greig GM; Slipetz D; Metters KM; Gordon R; Chan CC; Zamboni RJ
Bioorg Med Chem Lett; 2005 Feb; 15(3):527-30. PubMed ID: 15664806
[TBL] [Abstract][Full Text] [Related]
2. Comparison between two classes of selective EP(3) antagonists and their biological activities.
Belley M; Chan CC; Gareau Y; Gallant M; Juteau H; Houde K; Lachance N; Labelle M; Sawyer N; Tremblay N; Lamontagne S; Carrière MC; Denis D; Greig GM; Slipetz D; Gordon R; Chauret N; Li C; Zamboni RJ; Metters KM
Bioorg Med Chem Lett; 2006 Nov; 16(21):5639-42. PubMed ID: 16931013
[TBL] [Abstract][Full Text] [Related]
3. 2,3-Diarylthiophenes as selective EP1 receptor antagonists.
Ducharme Y; Blouin M; Carrière MC; Chateauneuf A; Côté B; Denis D; Frenette R; Greig G; Kargman S; Lamontagne S; Martins E; Nantel F; O'Neill G; Sawyer N; Metters KM; Friesen RW
Bioorg Med Chem Lett; 2005 Feb; 15(4):1155-60. PubMed ID: 15686932
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
[TBL] [Abstract][Full Text] [Related]
7. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.
Naganawa A; Matsui T; Ima M; Yoshida K; Tsuruta H; Yamamoto S; Yamamoto H; Okada H; Maruyama T; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Dec; 14(23):7774-89. PubMed ID: 16931028
[TBL] [Abstract][Full Text] [Related]
8. Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonists.
Hattori K; Tanaka A; Fujii N; Takasugi H; Tenda Y; Tomita M; Nakazato S; Nakano K; Kato Y; Kono Y; Murai H; Sakane K
J Med Chem; 2005 May; 48(9):3103-6. PubMed ID: 15857112
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
[TBL] [Abstract][Full Text] [Related]
10. 1,7-Disubstituted oxyindoles are potent and selective EP(3) receptor antagonists.
Zhou N; Polozov AM; O'Connell M; Burgeson J; Yu P; Zeller W; Zhang J; Onua E; Ramirez J; Palsdottir GA; Halldorsdottir GV; Andresson T; Kiselyov AS; Gurney M; Singh J
Bioorg Med Chem Lett; 2010 Apr; 20(8):2658-64. PubMed ID: 20303752
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship on the human EP3 prostanoid receptor by use of solid-support chemistry.
Juteau H; Gareau Y; Labelle M; Lamontagne S; Tremblay N; Carrière MC; Sawyer N; Denis D; Metters KM
Bioorg Med Chem Lett; 2001 Mar; 11(5):747-9. PubMed ID: 11266183
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
[TBL] [Abstract][Full Text] [Related]
13. Novel methylene-linked heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
[TBL] [Abstract][Full Text] [Related]
14. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
16. 3-Acrylamide-4-aryloxyindoles: synthesis, biological evaluation and metabolic stability of potent and selective EP3 receptor antagonists.
Zhou N; Zeller W; Zhang J; Onua E; Kiselyov AS; Ramirez J; Palsdottir G; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Mar; 19(5):1528-31. PubMed ID: 19188065
[TBL] [Abstract][Full Text] [Related]
17. Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonists.
Chen C; Yu J; Fleck BA; Hoare SR; Saunders J; Foster AC
J Med Chem; 2004 Jul; 47(16):4083-8. PubMed ID: 15267247
[TBL] [Abstract][Full Text] [Related]
18. Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists.
Greenspan PD; Fujimoto RA; Marshall PJ; Raychaudhuri A; Lipson KE; Zhou H; Doti RA; Coppa DE; Zhu L; Pelletier R; Uziel-Fusi S; Jackson RH; Chin MH; Kotyuk BL; Fitt JJ
J Med Chem; 1999 Jan; 42(1):164-72. PubMed ID: 9888841
[TBL] [Abstract][Full Text] [Related]
19. Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.
Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Masaaki Toda
Bioorg Med Chem; 2004 Sep; 12(17):4685-700. PubMed ID: 15358295
[TBL] [Abstract][Full Text] [Related]
20. EP1 antagonists for the treatment of inflammatory pain.
Hall A; Billinton A; Giblin GM
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):597-612. PubMed ID: 17786859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
